Search Within

Isabelle C Riviere

  1. "Jae Park"
  2. "Meeting abstract"
  3. "Bone Marrow Transplant"
  4. "Nursing"
Formats
  1. Meeting Abstract (11)
Groups
  1. Adult Leukemia (11)
  2. Bone Marrow Transplant (11)
  3. Center for Hematologic Malignancies (11)
  4. Department of Medicine (11)
  5. GSK Faculty (11)
  6. Hematologic Malignancies Research (11)

More Groups

People
  1. Jae Park (11)
  2. Renier Brentjens (11)
  3. Craig Sauter (9)
  4. Elizabeth Halton (9)
  5. Kevin Curran (9)
  6. Xiuyan Wang (9)

More People

Years
  1. 2021 (1)
  2. 2018 (2)
  3. 2017 (1)
  4. 2016 (1)
  5. 2015 (5)
  6. 2014 (1)
Publications
  1. Blood (7)
  2. Cancer Research (1)
  3. Haematologica (1)
  4. Journal of Clinical Oncology (1)
  5. Molecular Therapy (1)
Publishers
  1. American Society of Hematology (7)
  2. American Association for Cancer Research (1)
  3. American Society of Clinical Oncology (1)
  4. Ferrata Storti Foundation (1)
  5. Nature Publishing Group (1)

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The intestinal microbiota correlates with response and toxicity after CAR T cell therapy in patients with B-cell malignancies
    Meeting Abstract

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial
    Meeting Abstract

    Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Intestinal microbiota composition prior to CAR T cell infusion correlates with efficacy and toxicity
    Meeting Abstract

    Smith, M.; Littmann, E. R.; Slingerland, J. B.; Clurman, A.; Slingerland, A. E.; Taur, Y.; Schluter, J.; Park, J. H.; O'Cearbhaill, R.; Mailankody, S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Development and evaluation of a human single chain variable fragment (scFv) derived BCMA targeted CAR T Cell vector leads to a high objective response rate in patients with advanced MM
    Meeting Abstract

    Smith, E. L.; Mailankody, S.; Ghosh, A.; Masakayan, R.; Staehr, M.; Purdon, T. J.; Halton, E.; Diamonte, C.; Anant, P.; Bernal, Y.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T cells for cancer immunotherapy
    Meeting Abstract

    Curran, K. J.; Silverman, L. B.; Kobos, R.; Kernan, N. A.; Margossian, S. P.; Park, J. H.; Sauter, C. S.; Szenes, V.; Wang, X. Y.; O'Reilly, R. J.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Multi-center clinical trial of CAR T cells in pediatric/young adult patients with relapsed B-cell ALL
    Meeting Abstract

    Curran, K. J.; Riviere, I.; Silverman, L. B.; Kobos, R.; Shukla, N.; Steinherz, P. G.; Boulad, F.; Prockop, S.; Scaradavou, A.; Margossian, S. P.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Implications of minimal residual disease negative complete remission (MRD-CR) and allogeneic stem cell transplant on safety and clinical outcome of CD19 targeted 19-28z CAR modified T cells in adult patients with relapsed, refractory B-cell ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Purdon, T.; Halton, E.; Wang, Y.; Curran, K. J.; Sauter, C. S.; Sadelain, M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Efficacy and safety of CD19-targeted 19-28z CAR modified T cells in adult patients with relapsed or refractory B-ALL
    Meeting Abstract

    Park, J.; Riviere, I.; Wang, X.; Bernal, Y.; Purdon, T.; Halton, E.; Curran, K.; Sauter, C.; Sadelain, M.; Brentjens, R.
    Haematologica (2015)

    Fulltext@MSK | Save
  • Phase I clinical trial of autologous CD19-targeted 19-28z CAR T cells in adult patients with Relapsed or refractory B-ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Halton, E.; Quintanilla, H.; Curran, K.; Sauter, C.; Sadelain, M.; Brentjens, R. J.
    Molecular Therapy (2015)

    Fulltext@MSK | Save
  • Efficacy and safety of CD19-targeted 19-28z CAR modified T cells in adult patients with relapsed or refractory B-ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Purdon, T.; Halton, E.; Curran, K. J.; Sauter, C. S.; Sadelain, M.; Brentjens, R. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save